MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials ; day:7 ; month:5 ; year:2019 ; pages:1-11
Psychopharmacology ; (7.5.2019), 1-11
- Creator
-
Mithoefer, Michael C.
Feduccia, Allison A.
Jerome, Lisa
Mithoefer, Anne
Wagner, Mark
Walsh, Zach
Hamilton, Scott
Yazar-Klosinski, Berra
Emerson, Amy
Doblin, Rick
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-019-05249-5
- URN
-
urn:nbn:de:101:1-2019080301511204941942
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mithoefer, Michael C.
- Feduccia, Allison A.
- Jerome, Lisa
- Mithoefer, Anne
- Wagner, Mark
- Walsh, Zach
- Hamilton, Scott
- Yazar-Klosinski, Berra
- Emerson, Amy
- Doblin, Rick
- SpringerLink (Online service)
Other Objects (12)
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
Phase I Clinical Trials in Oncology
Common side effects of MDMA-assisted psychotherapy
Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
What inference for two-stage phase II trials?
Practical risk management in early phase clinical trials
Meta-analysis of randomized phase II trials to inform subsequent phase III decisions
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
Phase I Clinical Trials in Oncology
Common side effects of MDMA-assisted psychotherapy
Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
What inference for two-stage phase II trials?
Practical risk management in early phase clinical trials
Meta-analysis of randomized phase II trials to inform subsequent phase III decisions
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
Phase I Clinical Trials in Oncology
Common side effects of MDMA-assisted psychotherapy
Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
What inference for two-stage phase II trials?
Practical risk management in early phase clinical trials